Business Transition and Focus - The company transitioned from a P2P lending and microlending business to a focus on social e-commerce and healthcare services, changing its name from Hexindai Inc. to Akso Health Group in December 2021[203][217]. - The company is no longer engaged in P2P marketplace businesses and is focusing solely on healthcare and e-commerce[203][220]. - The company disposed of its social e-commerce business in May 2023 to focus on healthcare[355]. - The company has ceased issuing new loans since May 2019, with the outstanding balance of loan receivable being nil as of March 31, 2022[352]. Healthcare Services and Products - The company began selling COVID-19 Rapid Antigen test kits in March 2022 and has entered into a supply agreement for these kits[223]. - The company has engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscopes since April 2022 through its subsidiary Qingdao Akso[223]. - The healthcare segment is expected to experience steady growth due to intentional resource allocation by management[220]. - The company plans to open 2 vaccine research centers for AIDS and COVID-19 and 100 radiation oncology centers on the east coast of the U.S.[230]. - The company started its sales of medical devices in the US market in February 2022 and expanded to the PRC domestic market in April 2022[359]. Financial Performance - Net revenues for the fiscal years ended March 31, 2021, 2022, and 2023 were US$0, US$6.0 million, and US$13.2 million, respectively[355]. - Net losses for the same periods were US$34.8 million, US$16.8 million, and US$1.2 million, respectively[355]. - Total operating expenses for the fiscal year ended March 31, 2023, were US$15.5 million, an increase of 301.9% from US$3.9 million for the fiscal year ended March 31, 2022[373]. - General and administrative expenses for the fiscal year ended March 31, 2023, were US$15.5 million, a 481.7% increase from US$2.7 million in the prior year[374]. - Net loss from continuing operations for the fiscal year ended March 31, 2023, was US$13.1 million, compared to US$4.1 million in the prior year[377]. Customer and Market Dynamics - The company’s three main customers represented approximately 59.5%, 11.1%, and 10.1% of total revenues for the fiscal year ended March 31, 2023[234]. - The oncology healthcare service market in the U.S. is fragmented, with competition primarily from government-owned and private hospitals[235]. - The company faces intense competition in the COVID-19 diagnostic testing industry from various manufacturers and research institutions[237]. Regulatory and Compliance - The FDA regulates the development and marketing of medical devices, including the company's COVID-19 self-test kits, under the Federal Food, Drug, and Cosmetic Act[317]. - Medical devices are classified into three classes based on risk, with Class III devices requiring more rigorous premarket approval processes compared to Class I and II devices[322]. - The Class III Medical Device Operation License obtained by the company is valid for five years and can be renewed six months prior to expiration[228]. Cash Flow and Financial Obligations - As of March 31, 2023, cash and cash equivalents were US$7.9 million, a decrease of US$10.5 million from US$18.4 million as of March 31, 2022, primarily due to increased cash used in financing activities[384]. - The net cash used in financing activities for the fiscal year ended March 31, 2022, was US$27.5 million, compared to net cash generated of US$34.8 million for the previous fiscal year[384]. - The company has limited financial obligations denominated in U.S. dollars, minimizing the impact of PRC exchange control regulations on liquidity[389]. Intellectual Property and Compliance - The company has registered a website to protect its intellectual property, although it has not experienced material misappropriation to date[242]. - The PRC Anti-money Laundering Law requires financial institutions to adopt measures for client identification and report large or suspicious transactions[263]. - Non-compliance with consumer protection laws may result in civil liabilities, including refunds, compensation, and potential criminal penalties for severe violations[274].

Financial Performance - Net revenues for the six months ended September 30, 2022, were $11,872,421, compared to $245,924 for the same period in 2021, representing a significant increase[6]. - Gross profit for the six months ended September 30, 2022, was $1,141,220, compared to $245,924 in 2021, indicating a substantial improvement[6]. - The net income attributable to Akso's shareholders for the six months ended September 30, 2022, was $810,338, a significant turnaround from a loss of $8,916,114 in 2021[6]. - For the six months ended September 30, 2022, the net income was $826,436 compared to a net loss of $8,916,114 for the same period in 2021[12]. - The company reported a comprehensive loss of $2,371,626 for the six months ended September 30, 2022, compared to a loss of $8,128,145 in 2021, showing improvement[6]. - The Company reported net revenues of $11,876,023 for the six months ended September 30, 2022, a decrease from $246,552 in the same period of 2021[57]. - The Company generated $11,858,313 in revenue from medical devices for the six months ended September 30, 2022, with no revenue reported in the same period of 2021[57]. - For the six months ended September 30, 2022, three customers accounted for 84.4% of total revenues, indicating a significant customer concentration risk[107]. Expenses and Liabilities - Total operating expenses decreased from $8,715,752 in 2021 to $2,191,410 in 2022, a reduction of approximately 74.9%[6]. - Total current liabilities decreased from $38,394,202 to $10,977,240, a reduction of approximately 71.4%[1]. - Cash flows from operating activities resulted in a net cash used of $1,334,116, a significant decrease from the net cash provided of $824,655 in the prior year[12]. - The net cash used in financing activities was $27,513,849, contrasting with net cash provided of $9,340,265 in the same period last year[12]. - Total current liabilities decreased to $48,044 as of September 30, 2022, from $89,205 as of March 31, 2022, representing a reduction of approximately 46%[36]. - Total shareholders' equity decreased from $12,283,606 to $9,930,054, a decline of approximately 19.2%[4]. Cash and Assets - Cash and cash equivalents decreased from $21,925,322 to $9,990,561, a drop of approximately 54.4%[3]. - As of September 30, 2022, cash and cash equivalents at the end of the year were $9,990,561, down from $15,456,824 at the end of the previous year[12]. - Cash and cash equivalents decreased to $674,477 as of September 30, 2022, down from $2,394,869 as of March 31, 2022[36]. - Total current assets decreased from $50,624,351 to $20,870,986, a decline of approximately 58.8%[3]. - Total assets as of September 30, 2022, amounted to $20,907,294, a decrease from $50,679,784 as of March 31, 2021[180]. - Inventory value decreased to USD 899,555 as of September 30, 2022, from USD 7.80 million as of March 31, 2022[119]. - Accounts receivable increased significantly to USD 7.99 million as of September 30, 2022, compared to USD 85,386 as of March 31, 2022[113]. Business Operations and Strategy - The company is developing a new business as a cancer therapy and radiotherapy oncology service provider, planning to open 2 vaccine research centers and 100 radiation oncology centers on the U.S. east coast[16]. - In January 2022, the company established three centers in the U.S. and began sales of medical devices in the U.S. market, expanding its operational footprint[16]. - The company has ceased its P2P business and micro-lending operations since 2019, marking a strategic shift in its business model[15]. - The company plans to continue its market expansion in China with the sales of medical devices starting in April 2022[16]. - The company began its business in the US market for the sale of medical devices in February 2022, expanding its market presence[43]. Legal and Compliance - The company relies on the legal enforceability of its VIE structure, which poses risks if found non-compliant with PRC laws[30]. - The company initiated legal proceedings against Jiuzheng Company for defaults, with an allowance for uncollectible other receivables changing to US$4.1 million as of September 30, 2022[122]. - The company has a loan agreement with Webao Limited for US$2.0 million at a 0% interest rate, with a balance of US$2.0 million due as of March 31, 2022[136]. Shareholder Information - The company has 69,763,933 shares outstanding as of September 30, 2022, unchanged from March 31, 2022[4]. - The company has a total authorized number of ordinary shares of 500,000,000, with a par value of $0.0001 each[149]. - The company completed a private placement on September 17, 2021, raising approximately $10.02 million by selling 6,340,000 units at $1.58 per unit[150]. - As of September 30, 2022, there were 6,340,000 warrants outstanding, each with a weighted average exercise price of $3.00 and a remaining contractual life of 4 years[152]. - The company authorized a share repurchase program of up to $25 million, having repurchased 1,165,883 ADSs for a total consideration of $3,988,370[170]. Tax and Regulatory Matters - The company’s subsidiaries in the U.S. are subject to federal and state income taxes, with a federal tax rate of 21% and a state tax rate of 6.5% for New York[141]. - The company has a full valuation allowance on net deferred tax assets for the years ended March 31, 2022, 2021, and 2020, indicating uncertainty regarding realization[90]. Risks and Challenges - The ongoing COVID-19 pandemic continues to adversely affect the company's business and financial results, with uncertainty regarding its future impact[108]. - The company experienced a foreign currency translation adjustment due to the RMB's exchange rate, which was 7.1135 as of September 30, 2022, compared to 6.4434 as of September 30, 2021[100]. - The company has a vendor concentration risk, with one vendor accounting for 100% of the purchases in the medical devices business started in April 2022[107].

Regulatory Compliance and Risks - Akso Health operates primarily through its PRC subsidiaries, contractual arrangements with consolidated affiliated entities, and U.S. subsidiaries, with significant restrictions on foreign investment in certain sectors in China [17]. - The company consolidates the financial results of its Variable Interest Entities (VIEs) under U.S. GAAP, treating them as consolidated entities despite not holding direct equity interests [18]. - All PRC subsidiaries and consolidated affiliated entities have obtained necessary licenses, including Business Licenses, Internet Content Provision (ICP) Licenses, and Electronic Data Interchange (EDI) Licenses, but uncertainties remain regarding compliance with PRC regulations [23]. - The Data Security Law, effective September 1, 2021, imposes strict data security and privacy obligations, with potential fines of up to RMB 10 million for violations, which could adversely affect the company's operations [25]. - The company is subject to PRC regulations regarding overseas listings, which may require permissions from the China Securities Regulatory Commission (CSRC) and cybersecurity reviews for future offerings [24]. - The Holding Foreign Companies Accountable Act (HFCAA) may impact the trading of Akso Health's American Depositary Shares (ADSs) if the PCAOB cannot inspect its auditors for three consecutive years [32]. - The PCAOB has determined it cannot fully inspect registered public accounting firms in mainland China and Hong Kong, but Akso Health's auditor, Onestop Assurance PAC, is compliant and subject to regular PCAOB inspections [33]. - The company is subject to regulatory risks related to its previous microlending business, which may impact its operations and reputation [49]. - The company faces risks related to the PCAOB's ability to inspect its auditors, which could impact investor confidence and trading on U.S. exchanges [171]. - The SEC's HFCA Act may lead to delisting if the company's auditor is not subject to PCAOB inspections for consecutive years [173]. - The lack of PCAOB inspection access in China complicates the evaluation of audit quality, potentially affecting investor trust in financial statements [174]. - The company's auditor is based in Singapore and is registered with PCAOB, but potential inability for PCAOB to inspect could lead to delisting risks under the Holding Foreign Companies Accountable Act [175]. - The PCAOB secured complete access to inspect registered public accounting firms in mainland China and Hong Kong as of December 15, 2022, but future obstructions could lead to new determinations [176]. - U.S. public companies with significant operations in China face increased scrutiny and potential negative publicity, impacting share prices and business operations [177]. - The Holding Foreign Companies Accountable Act mandates that foreign companies must certify they are not controlled by foreign governments if PCAOB cannot audit them for three consecutive years, risking trading prohibitions [180]. - Companies in the technology sector are experiencing heightened regulatory scrutiny, which may lead to fines and changes in business practices [187]. - The PRC Cybersecurity Law requires personal information to be stored in China, and companies may face penalties for non-compliance, impacting operations [191]. - The PRC Data Security Law mandates legitimate data collection and processing, with potential penalties for violations, including business license revocation [194]. - The Personal Information Protection Law (PIPL) requires consent for using sensitive personal information, with non-compliance potentially leading to fines and operational impacts [195]. - Compliance with data privacy and protection laws may incur significant costs and restrict business operations, potentially affecting financial condition and ADS value [196]. - Failure to comply with PRC regulations on mergers and acquisitions could lead to severe fines and regulatory uncertainties regarding corporate structure [197]. - The M&A Rules require offshore special purpose vehicles to obtain approval from MOFCOM and CSRC for acquisitions and public listings, with unclear application affecting future strategies [198][201]. - Regulatory agencies may impose fines, limit operating privileges, or delay repatriation of proceeds from overseas financings, adversely impacting business and financial condition [199][204]. - Recent draft regulations require PRC companies seeking overseas listings to complete filing procedures with the CSRC, introducing additional compliance burdens [203]. - Changes in PRC government policies could significantly impact the ability to operate profitably, particularly regarding internet regulations and private ownership [206][208]. - The PRC legal system's uncertainties may affect the enforcement of contractual rights and the outcome of legal proceedings, posing risks to business operations [210][213]. - The interpretation and enforcement of PRC laws are subject to significant discretion, complicating compliance and legal protections for the company [212][214]. - The company may face challenges in enforcing legal rights due to the discretionary nature of PRC administrative and court authorities, which could adversely affect business operations [215]. - Recent regulatory opinions emphasize the need for stricter administration over illegal securities activities and increased supervision of overseas listings by Chinese companies, potentially leading to future compliance requirements [216]. Financial Performance and Projections - The company incurred a net loss of US$16.8 million for the fiscal year ended March 31, 2022 [53]. - The company intends to invest in improving its fulfillment infrastructure and technology platform to support a curated selection of products and additional value-added services [53]. - The company has a dividend policy set at approximately 15-25% of anticipated net income after tax, with a total dividend of US$0.40 per ordinary share approved in 2018 [39]. - Loans from the company to offshore subsidiaries amounted to US$12,017.2 million for the year ended March 31, 2022 [38]. - The company reported net loans from subsidiaries to VIEs of US$9,549.5 million [38]. - The company’s ability to achieve profitability depends on increasing its user base and optimizing its cost structure [53]. - The company may incur losses in the future due to ongoing investments and market uncertainties [53]. - The company has generated very little revenue from product sales and may never become profitable [120]. - The ability to generate future revenues depends heavily on successful completion of clinical trials and obtaining regulatory approvals for product candidates [120]. - Significant costs are anticipated for the commercialization of any approved product candidates, which may exceed expectations [122]. - The company may need additional funding to continue operations even if revenues are generated from product sales [122]. - Current cash and cash equivalents are believed to be sufficient for the next 12 months, but additional liquidity may be needed for investments or acquisitions [134]. - Labor costs in China are expected to continue increasing, which may adversely affect financial condition and results of operations [131]. - Ineffective internal controls over financial reporting could lead to material misstatements and loss of investor confidence [138]. - The company has not independently verified data from third-party sources, which may affect the accuracy of market projections [140]. Business Operations and Strategy - The company has ceased its online microlending business since May 2019, transitioning to a social e-commerce platform launched in May 2020 [50]. - The social e-commerce platform launched in May 2020 offers a wide variety of products, including food, beverages, cosmetics, and home appliances, with plans for further diversification to enhance revenue sources [55]. - The company relies on social networks like WeChat, QQ, and Weibo for user acquisition and engagement, with a significant portion of user traffic coming from member recommendations [58]. - The Elite Influencers Program, launched in August 2020, focuses on leveraging influential WeChat merchants to promote offerings, emphasizing the need to adapt to evolving social media platforms [60]. - Seasonal fluctuations significantly impact the company's revenue, with the fourth quarter typically contributing the largest portion due to increased marketing budgets and consumer spending during events like the 11.11 global shopping festival [68]. - The company faces intense competition in the social e-commerce industry, with competitors potentially having greater financial resources and brand recognition, which could pressure pricing and market share [64]. - The reliance on third-party merchants for product storage and delivery poses risks to service quality and brand reputation, as the company cannot directly control these aspects [66]. - The company must continuously enhance its platform's responsiveness and features to keep pace with rapid technological changes and evolving user preferences [56]. - Any disruption in relationships with major social networks could severely impact user growth and retention, affecting overall business performance [57]. - The company is subject to regulatory risks associated with social media marketing, which could lead to fines or penalties if compliance is not maintained [61]. - Maintaining brand reputation is critical, as negative perceptions regarding product authenticity or customer service could adversely affect user acquisition and retention [74]. - The company relies on third-party delivery logistics service providers for product delivery, which may affect performance and customer satisfaction due to potential interruptions [77]. - Customer service quality is critical; failures may lead to reputational damage and loss of market share [78]. - The company faces potential liability for counterfeit or unauthorized merchandise displayed on its platform, which could incur significant costs [80]. - Increasing focus on consumer protection laws in China poses challenges, especially regarding health and safety claims related to products sold [82]. - The company must comply with the E-Commerce Law, which imposes obligations on platform operators, including verifying merchants and ensuring cybersecurity [89]. - Cybersecurity risks are significant; breaches could lead to loss of confidential information and reputational harm [93]. - The company generates and processes large volumes of personal data, facing challenges in data protection and compliance with privacy laws [95]. - The technology infrastructure must be continuously upgraded to support business growth; failure to do so may impede operations [86]. - Disruptions to IT systems could materially affect service delivery and operational performance [84]. - The company plans to establish and operate cancer therapy and radiation oncology centers, focusing on providing a variety of radiotherapy services [107]. - New cancer therapy and radiation oncology centers generally have lower income and higher operating costs during initial stages, potentially leading to significant fluctuations in financial performance [111]. - The company may face challenges in recruiting qualified medical professionals for its new centers, which could impact service quality and patient attraction [108]. - The establishment of new centers involves substantial upfront costs, including labor, construction, and equipment expenses, which may delay profitability [111]. - The company operates in a heavily regulated industry, subject to laws regarding medical equipment procurement, service pricing, and licensing, which may constrain growth prospects [114]. - The company has taken measures in response to COVID-19, including remote work arrangements and suspension of offline customer acquisition activities, impacting operations and financial condition [101]. - The company’s ability to launch new products and services may be hindered by undetected errors or bugs in its software and algorithms, affecting customer experience [98]. - The company’s operations are vulnerable to natural disasters and health epidemics, which could disrupt services and lead to data loss [99]. - The company’s user information protection system may not be deemed sufficient under applicable laws, potentially resulting in loss of users and reputational damage [97]. Ownership Structure and Variable Interest Entities - The company operates its social e-commerce platform Xiaobai Maimai through contractual arrangements, consolidating the operating results of Hexin Digital and Wusu Company in its financial statements under U.S. GAAP [144]. - The company faces risks related to the changing political and trade relations between China and the United States, which could adversely affect its business and financial condition [142]. - The company’s ability to access capital and effectively operate in China may be impacted by potential changes in PRC laws and regulations regarding variable interest entity structures [145]. - Loans to the company's PRC subsidiary are subject to PRC regulations, including limits on the total amount of foreign debts, which could affect liquidity and business expansion [147]. - The company has contractual arrangements with its variable interest entities, which may not provide the same level of control as direct ownership, posing operational risks [155]. - The company’s ownership structure and contractual arrangements are currently deemed compliant with existing PRC laws, but uncertainties remain regarding future regulatory interpretations [144]. - The company may face significant disruptions if it fails to obtain necessary government approvals for future loans or capital contributions to its PRC subsidiary [150]. - The company’s ability to utilize proceeds from its initial public offering for funding its PRC operations is subject to regulatory restrictions [146]. - The company has undergone internal reorganization, resulting in Hexin E-Commerce holding 100% of Wusu Company’s equity interests [153]. - The company’s business operations may be adversely affected if any of its variable interest entities or their shareholders fail to perform their obligations under the contractual arrangements [155]. - Hexin Jiuding, Wusu Company, and Hexin Digital's shareholders may act against the company's interests, potentially leading to substantial costs and legal actions [156]. - The PRC legal system presents uncertainties that may limit the company's ability to enforce contractual arrangements with its variable interest entities [157]. - Conflicts of interest among shareholders of variable interest entities could adversely affect the company's business and financials [158]. - The company has exclusive purchase options for equity interests in Hexin Jiuding, Wusu Company, and Hexin Digital, but lacks other arrangements to address potential conflicts of interest [160]. - Related party transactions may be subject to audit by PRC tax authorities, which could result in material tax consequences if deemed inconsistent with arm's length principles [163]. - If variable interest entities face bankruptcy or liquidation, the company may not recover assets or maintain ownership [164]. - Hexin Digital holds critical assets for the company's social e-commerce business, including licenses and trademarks, which are protected under current contractual arrangements [165].

Foreign Exchange and Currency Risk - The company experienced a foreign exchange translation loss of US$6.1 million for the fiscal year ended March 31, 2019, and a loss of US$5.6 million for the fiscal year ended March 31, 2020, but reported a gain of US$3.9 million for the fiscal year ended March 31, 2021[613]. - The RMB depreciated by approximately 6.89% against the U.S. dollar from April 2018 to March 2019, while it appreciated by approximately 1.1% against the U.S. dollar from April 2019 to March 2020[615]. - The company’s exposure to foreign exchange risk primarily relates to cash denominated in U.S. dollars from the initial public offering and a senior unsecured note issued[613]. - The company cannot predict how market forces or government policy may impact the exchange rate between the RMB and the U.S. dollar in the future[616]. Initial Public Offering - The company raised approximately US$43.3 million in net proceeds from its initial public offering of 5,036,950 ADSs at an initial offering price of US$10.00 per ADS, which closed on November 3, 2017[626]. - As of the date of the annual report, the company had used all the net proceeds received from its initial public offering[626]. Internal Control and Financial Reporting - Management concluded that the internal control over financial reporting was effective as of March 31 for the years 2019, 2020, and 2021[630]. - There were no changes in the internal control over financial reporting during the fiscal year ended March 31, 2021, that materially affected the internal control[633]. - The company’s management evaluated the effectiveness of disclosure controls and procedures and concluded they were effective as of March 31, 2021[629]. Interest Rate Risk - The company has not been exposed to material risks due to changes in market interest rates and has not used any derivative financial instruments to manage interest risk exposure[617].

Financial Performance - For the fiscal year ended March 31, 2020, the company reported net revenues of $11,435,060, a decrease of 81.4% compared to $61,330,504 in the previous year[15]. - The total operating costs and expenses for the fiscal year 2020 were $79,962,794, significantly up from $56,232,736 in 2019, marking an increase of 42.2%[15]. - The company experienced a net loss of $71,198,379 for the fiscal year 2020, compared to a net income of $5,532,581 in 2019, indicating a substantial decline in profitability[15]. - Cash and cash equivalents decreased to $10,925,208 as of March 31, 2020, down from $57,372,128 in the previous year, reflecting a decline of 81.0%[17]. - Total assets as of March 31, 2020, were $78,382,476, a decrease from $173,255,842 in 2019, representing a decline of 54.7%[17]. - The company’s basic net income (loss) per share for the fiscal year 2020 was $(1.46), compared to $0.11 in 2019, highlighting a significant downturn in earnings per share[15]. - The company experienced a net cash outflow from operating activities in both 2020 and 2019, indicating potential liquidity challenges[54]. Regulatory Environment - The company ceased to offer new loans for online investors' subscription since November 2019 due to regulatory changes, impacting its operational strategy[20]. - The company has been subject to regulatory uncertainties that may materially affect its growth prospects in the microlending business[29]. - Compliance with regulatory requirements is critical, as any violation could necessitate a material change to the business model, adversely impacting operations[42]. - The evolving regulatory framework for the consumer lending marketplace in China may impact the company's reputation and operational results, especially if associated with non-compliant companies[44]. - The regulatory environment for online microlending companies is evolving, with a suspension of approvals for new online microlending companies since November 2017[94]. - The company must ensure compliance with existing and future laws to avoid sanctions, including the potential revocation of business licenses, which could materially affect operations[87]. - The PRC government may introduce a licensing regime for the marketplace lending service industry, which could hinder the company's ability to operate if licenses are not obtained timely[82]. Business Operations - The company has shifted its focus entirely to credit loans since the third quarter of the fiscal year ended March 31, 2018, with all loans facilitated being credit loans in the fiscal years ended March 31, 2019 and 2020[155]. - The company launched the Xiaobai Maimai platform in May 2020, which offers high-quality products and rewards users for purchases, aiming to enhance user engagement and retention[22]. - The company has experienced a decrease in both the number of borrowers and loan volume facilitated on its marketplace in the fiscal years ended March 31, 2019, and 2020[26]. - The company is in the process of applying for an online microcredit company license in China to refine its business model and identify new opportunities[144]. - The company has connected its credit business assets database with the PBOC Credit Reference Center, enhancing compliance with government regulations but also exposing it to additional cybersecurity risks[33]. Risk Management - The company has stringent risk management protocols in place, but there are concerns about the adequacy of these measures to prevent fraud and assess credit risk effectively[30]. - The company has developed a risk management system that includes database analysis, anti-fraud analysis, manual verification, and post-loan risk management[184]. - The company closely monitors borrower repayments to identify non-payment signs, updating credit scores and grades accordingly[189]. - A risk reserve liability policy protects investors up to the full amount of their investment and accrued interest in case of borrower default, with approximately 1% to 2% of the loan principal set aside as a reserve[194]. Market Trends - The social e-commerce industry in China grew from approximately RMB84.2 billion (US$11.9 billion) in 2018 to an expected RMB564.4 billion (US$79.7 billion) in 2021[22]. - The total addressable market for loans is estimated to grow from RMB410.3 billion (US$57.9 billion) in 2018 to RMB528.4 billion (US$74.6 billion) in 2023, with a CAGR of 5.2%[37]. - Broader macroeconomic factors, such as interest rates and unemployment, may adversely affect borrower interest and investor lending, potentially leading to a decline in loan volume and revenues[54]. Corporate Governance - The company is classified as a "controlled company" under NASDAQ rules, allowing it to phase in compliance with certain corporate governance requirements, which may adversely affect public shareholders[126]. - The company is an emerging growth company and has opted out of certain reduced reporting requirements, including auditor attestation requirements under Section 404[131]. - The company is a foreign private issuer, exempt from certain provisions applicable to U.S. domestic public companies, including quarterly reporting on Form 10-Q[131]. - The company’s ability to expand and engage in corporate transactions may be limited by the substantial influence of existing shareholders[126]. Financial Compliance - The company has not made adequate contributions to employee benefit plans as required by PRC regulations, which may result in penalties and adversely affect its financial condition[109]. - The PRC tax authorities may audit related party transactions, potentially leading to increased tax liabilities if deemed inconsistent with arm's length principles[76]. - The company is subject to various PRC regulations regarding the conversion of foreign currency registered capital into RMB, which may limit its ability to fund operations effectively[104]. Investor Relations - The board of directors approved an annual dividend policy set at approximately 15-25% of anticipated net income after tax, with a total dividend of $0.40 per ordinary share for the fiscal year ended March 31, 2019[123]. - The trading price of the company's ADSs has fluctuated between US$0.42 and US$3.88 in 2019, indicating potential volatility influenced by market and industry factors[120]. - Short selling practices may negatively impact the market price of the company's ADSs, as short sellers may publish negative opinions to drive down prices[121].

Financial Data and Key Metrics Changes - In Q1 2020, net revenue was $4.9 million, a decrease of 90.5% from the same period last fiscal year [14] - Volume of credit loans facilitated through the peer-to-peer marketplace was $28.2 million, down from $2.9 billion during the same period last fiscal year [14] - Operating costs and expenses were $12.6 million, a decrease of 18.9% from the same period last fiscal year [14] - Net loss was $7.2 million, compared to net income of $29.7 million during the same period last year [16] - Basic loss per common share was $0.15 compared to basic earnings per share of $0.62 in the same period of fiscal year 2019 [16] Business Line Data and Key Metrics Changes - The loan assistance business is expected to drive future growth alongside the P2P business [7] - Loan volumes funded by institutional partners accounted for approximately 20% of total loans facilitated during the quarter [9] - Microfinance loan products accounted for approximately 22% of total loan volume during Q1 2020 [22] Market Data and Key Metrics Changes - The market remains challenging due to an uncertain regulatory environment affecting the P2P industry [7] - Demand from partner institutions for short-term, small-amount loans is growing, reflecting trust in the quality of underlying assets [11] Company Strategy and Development Direction - The company is strategically repositioning its business by developing a loan assistance business to drive future growth [7] - Partnerships with licensed financial institutions are being developed to diversify funding sources and ensure sustainable growth [9][27] - The company aims to leverage its experience in borrower acquisition and risk management to enhance the loan assistance business [27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the future of the loan assistance business despite the decline in the P2P business [10] - The company is committed to creating value for shareholders and users through its share repurchase program [17] - Management believes that the loan assistance business will allow for growth regardless of the regulatory environment for the P2P industry [11][18] Other Important Information - The company has repurchased nearly 1.2 million ADS for approximately $4 million at an average price of $3.4 per share [17] - The company is compliant with new regulations requiring P2P lending companies to connect to the Credit Reference Center at the People's Bank of China [31] Q&A Session Summary Question: Percentage of borrowers acquired from online channels - In Q1, 42% of borrowers were acquired online and 58% offline, with microfinance loans contributing significantly to online acquisitions [22] Question: Advantages of loan assistance compared to P2P business - Loan assistance has advantages such as strong demand for investment opportunities and partnerships with licensed financial institutions, reducing regulatory uncertainty [25][26] Question: Remaining share repurchase authorization - Approximately 1,160,000 ADS have been repurchased under the share repurchase program, with ongoing evaluations based on market conditions [29] Question: Timing for P2P lending companies to connect to the Credit Reference Center - The company has already connected its systems to Baihang Credit and began sharing credit data in January, ensuring compliance with new regulations [31]

Financial Performance - Total revenue for the fiscal year ended March 31, 2019, was $61,330,504, a significant increase from $22,920,543 in 2017, representing a growth of approximately 167%[7] - Operating costs and expenses for the same period reached $56,232,736, up from $13,006,997 in 2017, indicating an increase of about 333%[7] - Net income for the fiscal year 2019 was $5,532,581, compared to a net loss of $350,171 in 2015, showing a turnaround in profitability[7] - The company reported a comprehensive loss of $(603,606) in 2019, contrasting with a comprehensive income of $71,538,768 in 2018, highlighting volatility in financial performance[7] - Cash and cash equivalents as of March 31, 2019, were $57,372,128, a decrease from $132,622,467 in 2018, reflecting a decline of approximately 57%[9] Assets and Liabilities - Total assets increased to $173,255,842 in 2019 from $28,382,131 in 2017, marking a growth of about 511%[9] - Total liabilities rose to $46,752,684 in 2019, up from $4,877,775 in 2017, which is an increase of approximately 855%[9] Market Challenges - The number of borrowers and loan volume facilitated on the marketplace decreased in the fiscal year ended March 31, 2019, indicating potential challenges in user retention and loan growth[12] - The company may face difficulties in maintaining its growth rate due to an evolving regulatory environment and increased competition in the marketplace lending industry[11] - The company faces challenges in attracting sufficient loan capital from investors to meet borrower demand, which could significantly impact the volume of loans facilitated on its marketplace[14] Regulatory Environment - Regulatory uncertainties in the online microlending industry may materially affect the company's growth prospects and results of operations[16] - The company is at risk of non-compliance with regulatory requirements due to its current arrangements with Jiangxi Bank, which may necessitate a material change to its business model[30] - The evolving regulatory landscape for the marketplace lending service industry may impose new restrictions that could impact business operations[64] - The PRC Foreign Investment Law, effective January 1, 2020, introduces uncertainties regarding the interpretation and implementation of foreign investment regulations, potentially impacting corporate structure and governance[66] Risk Management - The company has implemented stringent risk management protocols to assess borrower credit risk, but acknowledges that its risk management system may have loopholes that could affect reliability[16] - The company continuously optimizes its risk management systems every three to six months to enhance security and efficiency[156] - The company has maintained a risk reserve liability policy, protecting investors up to the full amount of the investment and accrued interest, with approximately 1% set aside for secured loans and 2% for credit loans[162] Investor Relations - The company is focused on optimizing investor composition to include more institutional investors, which typically invest larger amounts compared to individual investors[14] - The repeat investor rate indicates strong customer loyalty, with 82.4% of first-time investors from 2015 having invested more than once by March 31, 2019[121] - The company’s marketing efforts include traditional and online media, but ineffective channels or increased costs could harm brand reputation and market share[29] Loan Facilitation - In the fiscal year ended March 31, 2019, the total amount of loans facilitated by the company was RMB3,788.2 million (US$564.9 million), a decrease from RMB8,332.1 million (US$1,257.6 million) in the previous fiscal year[118] - The company facilitated loans to 84,891 borrowers in the fiscal year ended March 31, 2019, down from 101,172 borrowers in the fiscal year ended March 31, 2018[118] - The average approval rate for medium-sized credit loans was 9% and 11% in the third and fourth quarters of the fiscal year ended March 31, 2019, compared to 18% and 12% in the first and second quarters of the same fiscal year[118] Compliance and Legal Issues - The company has implemented various anti-money laundering policies and procedures in cooperation with Jiangxi Bank, including internal controls and "know-your-customer" procedures[77] - The company has not faced any fines or penalties under PRC laws prohibiting illegal fundraising to date, as it only acts as a service provider facilitating loans between borrowers and investors[78] - The company is subject to ongoing regulatory scrutiny, with potential penalties for non-compliance including fines ranging from RMB500,000 (US$74,502) to RMB1,000,000 (US$149,004)[182] Corporate Governance - The company has adopted an amended and restated memorandum and articles of association that includes anti-takeover provisions, potentially limiting shareholder rights[104] - The company is classified as a "controlled company" under NASDAQ rules, allowing it to phase in compliance with independent committee requirements, which may affect shareholder protections[104] - The voting rights of ADS holders are limited by the deposit agreement, requiring them to provide voting instructions to the depositary[108] Economic Factors - Broader macroeconomic factors, such as interest rates and unemployment, could deter borrowers and investors, negatively impacting loan volume and revenue[41] - The company relies heavily on internet infrastructure in China; disruptions could adversely affect operations and access to loan products[41] - Labor costs in China are projected to continue increasing, which may adversely affect the company's financial condition if costs cannot be passed on to users[44] Future Outlook - The company believes its current cash and cash equivalents, along with anticipated cash flows, will meet working capital requirements for the next 12 months, but may need additional liquidity for future investments[38] - The company has no current plans for acquisitions but may pursue them in the future, which could involve complex corporate structures and tax implications[95]

Financial Data and Key Metrics Changes - In Q4 2019, net revenue was US$4.1 million, a decrease of 85% year-over-year, primarily due to a significant decrease in the volume of credit loans facilitated, which fell to US$61.7 million from US$418.4 million in the same quarter last year [15][18] - On a sequential basis, net revenue increased by 117% as the market recovered [16] - Net income was US$2.8 million compared to US$17 million in the same period last year, with basic EPS at US$0.06 compared to US$0.36 [17][18] Business Line Data and Key Metrics Changes - Total loans facilitated doubled sequentially to US$61.7 million, with net revenue increasing to US$4.1 million [8] - Gross billing amounts net of VAT more than tripled sequentially to US$9 million, with net income at US$2.8 million [8] Market Data and Key Metrics Changes - The number of first-time investors on the marketplace increased by 39% compared to the previous quarter [8] - M3+Net Charge-Off Rates remained low and steady at 6%, reflecting effective risk management systems [9] Company Strategy and Development Direction - The company launched an online microfinancing loan business in January 2019 to diversify revenue streams, targeting younger demographics [11][12] - Partnerships with financial institutions like Bohai International Trust and Kunming Aotou are expected to enhance funding sources and drive growth [10] Management's Comments on Operating Environment and Future Outlook - Management believes the worst of the market environment is behind them, with improved investor confidence and a positive outlook for the industry [8][13] - The company is optimistic about future growth and is focused on regulatory compliance and expanding its funding sources [13][20] Other Important Information - The company maintained a strong cash position of US$57.4 million as of March 31, 2019, and has initiated a US$25 million share repurchase program [19] - The company has repurchased approximately 1.2 million ADS at an average price of US$3.4 per ADS [20] Q&A Session Summary Question: Will sales and marketing expenses increase as business recovers? - Management indicated that costs will likely increase at a lower rate than business volume, with room for leveraging operational costs [24] Question: What is the average client profile for microfinancing compared to traditional lending? - The typical demographic for microfinancing is younger, and management is confident in maintaining a low delinquency rate [26] Question: Can you discuss the economics behind the improved gross billing ratio? - The gross billing ratio improved as more lenders regained confidence, and management believes this level can be maintained [28] Question: Any directional comments for Q1 and fiscal 2020 regarding loans and revenue? - Management suspended providing detailed guidance but has internal targets to recover to previous fiscal year levels [30] Question: Will U.S.-China tariff negotiations impact lending activity? - Management refrained from commenting on macroeconomic factors, focusing instead on operational performance [34]